REGN
HealthcareRegeneron Pharmaceuticals, Inc.
Prev Close
$746.61
Open
$754.55
High
$758.98
Low
$741.89
Volume
292.9K
Market Cap
$77.57B
P/E
17.89
Div Yield
0.00%
Over the past 12 months, insider activity at Regeneron Pharmaceuticals, Inc. (REGN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 25 insider sales totaling $303.86M. The most recent insider transaction was by RYAN ARTHUR F (director), who sold $52.6K worth of shares on Mar 3, 2026. Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $77.57B.
REGN Insider Trading Activity
REGN Insider Buying Activity
The following table shows recent insider purchases of Regeneron Pharmaceuticals, Inc. (REGN) stock reported via SEC Form 4 filings.
No insider buying activity found for REGN in the last 12 months.
REGN Insider Selling Activity
The following table shows recent insider sales of Regeneron Pharmaceuticals, Inc. (REGN) stock reported via SEC Form 4 filings.